Buradasınız

Anasayfa » Content

Güney Marmara Bölgesi Akut Miyeloid Löseminin Epidemiyolojik Özellikleri

Epidemiological Characteristics of Acute Myelogenous Leukemia in Southern Marmara Region of Türkiye

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
De novo acute myelogenous leukemia (AML) cases that were followed up and treated between the years 1994-1999 in Hematology Division of Medical Faculty of Uludağ University were assessed retrospectively according to parameters concerning age, sex, morphologic subgroup, occupation and region. It was established that of 165 de novo acute myelogenous leukemia cases 59.4% were male (98 cases), 40.6% female (67 cases), mean age was 46, the lowest age 14, the highest age 89. The male/female ratio was 1.4. The ages of most of the cases (32.7 %) were between 46-60 years. Male and female cases showed similar age distribution. Subgroup distribution was as follows: 5.5% of cases were M0, 12.1% M1, 27.9% M2, 15.7% M3, 21.8% M4, 9.7% M5, 3.6% M6 and 3.6% M7. Subgroup distribution was similar for male and female cases. 69.1 percent of cases were living in the cities and 30.9% in the rural area. It was found that the rate of farmers was 13.3%, workers 15.8%, traders 13.3%, civil servants 8.5%, retarded civil servants 10.9%, health care servants 2.4%, students 3% and housewives 32.7%.
Bookmark/Search this post with
Abstract (Original Language): 
Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları Hematoloji Bilim Dalında 1994-1999 yılları arasında takip ve tedavi edilen de novo akut miyeloid (AML) lösemi olguları cinsiyet, yaş, morfolojik alt grup, meslek, yaşanılan bölge özelliklerine göre retrospektif olarak incelendi. Toplam 165 akut miyeloid lösemi olgusundan erkeklerin %59,4 (98 olgu), kadınların %40,6 (67 olgu) oranını oluşturduğu, en küçük yaşın 14, en büyük yaşın 89 ve ortalama yaşın 46 olduğu saptandı. Erkek/kadın oranı 1.4/1 olarak belirlendi. En fazla olgunun (%32,7) 46-60 yaş döneminde olduğu tesbit edildi Erkek ve kadın olgularının aynı yaş grupları içersinde farklılık göstermeden dağılımı belirlendi. Alt grupların dağılımında M0: %5,5, M1: %12,1, M2: %27,9, M3: %15,7, M4: %21,8, M5: %9,7, M6: %3,6, M7: %3,6 oranında saptandı. Erkek ve kadınlar arasında alt grup dağılımı yönünden fark gözlenmedi. Olguların %69,1'nin şehir ortamında ve %30,9'nun kırsal kesim ortamında yaşadıkları belirlendi. Çiftçilerin %13,3, işçilerin %15,8, esnafların %13,3, masa başı görev yapan memurların %8,5, emekli memurların %10,9, sağlık mensublarının %2,4, öğrencilerin %3 ve ev hanımlarının %32,7 oranını oluşturdukları saptandı
FULL TEXT (PDF): 
PDF icon arastirmax-guney-marmara-bolgesi-akut-miyeloid-loseminin-epidemiyolojik-ozellikleri.pdf
  • 2
33-37
  • Turkish

REFERENCES

References: 

1. Lichtman MA, Liesveld JL. Acute myelogenous leukemia. In:
Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn
U (eds). Williams Hematology. Sixth Edition. New York:
McGraw-Hill Co; 2001. 1047-83.
2. Greer JP, Baer MR, Kinney MC. Acute myelogenous leukemia.
In: Lee GR, Lukens J, Paraskevas F, Greer JP, Rodgers
GM (eds). Wintrobe's Clinical Hematology. 10
th
Edition.
Giza, Egypt: Mass Publishing Co; 1999. 2272-319.
3. Sorensen JT, Gerald K, Bodensteiner D, Holmes FF. Effect of age
on survival in acute leukemia 1950-1990. Cancer
1993;72:1602-6.
4. Sebban C, Archimbaud E, Coiffer B, Guyotat D, Treille-Ritouet
D, Maupas J, Fiere D. Treatment of acute myeloid
leukemia in elderly patients. A retrospective study. Cancer
1988;61:227-31.
5. Rowe JM. Acute leukemias in adults. Mazza JJ (ed). Manual of
Clinical Hematology. New York: Marshfield Clinic. 1995.
222-35.
6. Hernandez J A, Land KJ, McKenna RW. Leukemias, myeloma,
and other lymphoreticular neoplasms. Cancer 1995;75:381-
94.
7. Kinney MC, Lukens JN. Classification and differentiation of the
acute leukemias. In: Lee GR, Lukens J, Paraskevas F,
Greer JP, Rodgers GM (eds). Wintrobe's Clinical
Hematology. 10
th
Edition. Giza, Egypt: Mass Publishing
Co; 1999. pp 2209-40.
8. Greaves MF. Aetiology of acute leukaemia. Lancet
1997;349:344-9.
9. Lancet JE, Willman CL, Bennett JM. Acute myelogenous
leukemia and aging. Clinical interactions. Hematol Oncol
Clin North Am 2000;14:251-67.
10. Jackson N, Menon BS, Zarina W, Zawawi N. Why is acute
leukemia more common is males? A possible sexdetermined risk linked to the ABO blood group genes. Ann
Hematol 1999;78:233-6.
11. Knox-Macaulay HHM, Brown LC. Descriptive epidemiology of
de novo acute leukaemia in the sultanate of Oman. Leuk
Res 2000;24:589-94.
12. Cairney AE, McKenna R, Arthur DC, Nesbit ME Jr, Woods WG.
Acute megakaryoblastic leukaemia in children. Br J
Haematol 1986;63:541-54.
13. Roggli VL, Saleem A. Erythroleukemia. A study of 15 cases and
literature review. Cancer 1982;49:101-8.
14. Ruiz-Argüelles GJ. Promyelocytic Leukemia in Mexican
Mestizos. Blood 1997;89:348.
15. Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ,
Levine AM. High frequency of acute promyelocytic
leukemia among latinos with acute myeloid leukemia.
Blood 1996;87:308-13.
16. Hassan K, Ikram N, Shah SH. A morphological pattern of 234
cases of leukemias. J Pak Med Assoc 1994;44:145-8.
17. Bethwaite P, McLean D, Kennedy J, Pearce N. Adult-onset acute
leukemia and employment in the meat industry: a New
Zealand Case-Control Study. Cancer Causes Control
2001;12:635-43.

Thank you for copying data from http://www.arastirmax.com